GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Longduoduo Co Ltd (OTCPK:LDDD) » Definitions » EV-to-EBITDA

Longduoduo Co (Longduoduo Co) EV-to-EBITDA : 111.02 (As of May. 09, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Longduoduo Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Longduoduo Co's enterprise value is $157.98 Mil. Longduoduo Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $1.42 Mil. Therefore, Longduoduo Co's EV-to-EBITDA for today is 111.02.

The historical rank and industry rank for Longduoduo Co's EV-to-EBITDA or its related term are showing as below:

LDDD' s EV-to-EBITDA Range Over the Past 10 Years
Min: -3904.71   Med: 111.14   Max: 22340.61
Current: 111.02

During the past 3 years, the highest EV-to-EBITDA of Longduoduo Co was 22340.61. The lowest was -3904.71. And the median was 111.14.

LDDD's EV-to-EBITDA is ranked worse than
96.58% of 117 companies
in the Medical Diagnostics & Research industry
Industry Median: 16.49 vs LDDD: 111.02

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-09), Longduoduo Co's stock price is $5.50. Longduoduo Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.034. Therefore, Longduoduo Co's PE Ratio for today is 161.76.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Longduoduo Co EV-to-EBITDA Historical Data

The historical data trend for Longduoduo Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Longduoduo Co EV-to-EBITDA Chart

Longduoduo Co Annual Data
Trend Jun21 Jun22 Jun23
EV-to-EBITDA
- - 19,785.24

Longduoduo Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - -2,347.31 19,785.24 297.74 142.03

Competitive Comparison of Longduoduo Co's EV-to-EBITDA

For the Diagnostics & Research subindustry, Longduoduo Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Longduoduo Co's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Longduoduo Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Longduoduo Co's EV-to-EBITDA falls into.



Longduoduo Co EV-to-EBITDA Calculation

Longduoduo Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=157.983/1.423
=111.02

Longduoduo Co's current Enterprise Value is $157.98 Mil.
Longduoduo Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.42 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Longduoduo Co  (OTCPK:LDDD) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Longduoduo Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=5.50/0.034
=161.76

Longduoduo Co's share price for today is $5.50.
Longduoduo Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.034.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Longduoduo Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Longduoduo Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Longduoduo Co (Longduoduo Co) Business Description

Traded in Other Exchanges
N/A
Address
Ordos Street, 419, Floor 4, Comprehensive Building, Second Light Hospital, Yuquan District, Inner Mongolia, Hohhot, CHN, 010000
Longduoduo Co Ltd through its operating subsidiaries engaged in the business of providing preventive healthcare solutions. It provides a wide range of comprehensive preventive healthcare services including disease screening, healthcare treatments, healthcare products, and other services. The company mainly focuses on the prevention of myocardial infarction, cerebral infarction, hemiplegia, and cardiovascular and cerebrovascular diseases. The company's revenues are generated from its customers in the People's Republic of China.

Longduoduo Co (Longduoduo Co) Headlines

No Headlines